Drugs / Oligomeric Procyanidin Complex
last change Jul 2018 re-read 3 minutes ago

Oligomeric Procyanidin Complex

Developed for
prostate cancer
Investigated by
Medical University of South Carolina

Trials 1

20192020202120222023202420252026
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 1 NCT03465345 Jul 2018 prostate cancer Medical University of South Carolina Withdrawn No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as Oligomeric Procyanidin Complex ClinicalTrials.gov intervention name — accepted as the source's own label NCT03465345 ↗